Related Experiment Video
Updated: Jul 24, 2026

07:36
Isolation of Human Lymphatic Endothelial Cells by Multi-parameter Fluorescence-activated Cell Sorting
Published on: May 1, 2015
Massive localized lymphedema: additional locations and association with hypothyroidism
Human Pathology
|October 3, 2000
Summary
Massive localized lymphedema (MLL) in morbidly obese patients presents as huge, longstanding masses. This condition, distinct from liposarcoma, may be linked to hypothyroidism and warrants clinical and pathological recognition.
Area of Science:
- Dermatology
- Pathology
- Endocrinology
Background:
- Massive localized lymphedema (MLL) is a recently described entity affecting morbidly obese patients.
- This report details a second series of MLL cases, expanding on initial findings.
Observation:
- Six adult cases presented with large, long-standing MLL masses in various locations including thigh, scrotum, and abdomen.
- Lesions measured up to 75 cm in diameter and weighed over 12,000 g, with overlying skin showing signs of chronic lymphedema.
- Differential diagnoses included lipoma, cellulitis, and well-differentiated liposarcoma due to the marbled appearance.
Findings:
- Histological examination ruled out liposarcoma, revealing reactive features such as lymphatic vascular ectasia, fibrosis, edema, and ischemic changes like fat necrosis.
- The diagnosis of MLL was established based on these reactive and ischemic findings.
Implications:
- Recognition of MLL is crucial for clinicians and pathologists to prevent misdiagnosis as low-grade liposarcoma.
- Potential contributing factors include lymphatic obstruction by pannus or surgery, with a possible association with hypothyroidism suggested by two cases.
Related Concept Videos
Hyperthyroidism I: Introduction
Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
Hyperthyroidism II: Pathophysiology
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Graves' Disease I: Introduction
Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
Graves Disease II: Pathophysiology
Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
Goiter
Goiter refers to an abnormal enlargement of the thyroid gland that may appear as a diffuse goiter (uniform enlargement) or nodular (single or multiple nodules). Functionally, it is classified as nontoxic (normal/low hormone levels) or toxic (excess hormone production).PathophysiologyDiffuse thyroid enlargement typically results from prolonged stimulation by thyroid-stimulating hormone (TSH) or TSH-like agents, commonly seen in hypothyroidism or iodine deficiency. In contrast, in hyperthyroid...
Hypothyroidism II: Pathophysiology
Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...

